PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-79

  1. 593 Posts.
    lightbulb Created with Sketch. 135
    I was having a look at the options yesterday thinking it's not a bad way of getting exposure.

    I sold about 70% of my shares at prices between 40 cents and 30 cents on the way down. Took a massive hit, as I was overexposed to this company (my fault) and now hold enough if it gets back to $3.85 I break even.

    Like many others, lost any confidence or belief in the company and in particular PR. I find my greed gene being aroused once again after the recent updates and talk of deals, etc., but will run with what I have as once bitten......

    GLTA, especially those continuing to buy. With 98% probability of success in P3, this decision from FDA really is a company maker.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.